SEER INC (SEER)
US81578P1066 - Common Stock
Taking everything into account, SEER scores 4 out of 10 in our fundamental rating. SEER was compared to 58 industry peers in the Life Sciences Tools & Services industry. SEER has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, SEER is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year SEER has reported negative net income.
In the past year SEER has reported a negative cash flow from operations.
In the past 5 years SEER always reported negative net income.
In the past 5 years SEER always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of SEER (-19.78%) is worse than 69.49% of its industry peers.
SEER's Return On Equity of -21.74% is in line compared to the rest of the industry. SEER outperforms 42.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.78% | ||
| ROE | -21.74% | ||
| ROIC | N/A |
ROA(3y)-17.34%
ROA(5y)-15.33%
ROE(3y)-18.9%
ROE(5y)-16.51%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 51.09%, SEER perfoms like the industry average, outperforming 55.93% of the companies in the same industry.
SEER does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 51.09% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SEER does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SEER has been increased compared to 1 year ago.
The number of shares outstanding for SEER has been reduced compared to 5 years ago.
SEER has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of 1.03, we must say that SEER is in the distress zone and has some risk of bankruptcy.
SEER has a worse Altman-Z score (1.03) than 66.10% of its industry peers.
SEER has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.03 |
ROIC/WACCN/A
WACC12.2%
2.3 Liquidity
A Current Ratio of 25.00 indicates that SEER has no problem at all paying its short term obligations.
SEER has a better Current ratio (25.00) than 100.00% of its industry peers.
SEER has a Quick Ratio of 24.66. This indicates that SEER is financially healthy and has no problem in meeting its short term obligations.
SEER's Quick ratio of 24.66 is amongst the best of the industry. SEER outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 25 | ||
| Quick Ratio | 24.66 |
3. Growth
3.1 Past
SEER shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.72%, which is quite good.
SEER shows a small growth in Revenue. In the last year, the Revenue has grown by 7.47%.
The Revenue has been growing by 193.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)8.72%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q22.22%
Revenue 1Y (TTM)7.47%
Revenue growth 3Y193.35%
Revenue growth 5YN/A
Revenue growth Q2Q-3.73%
3.2 Future
SEER is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.89% yearly.
The Revenue is expected to grow by 61.20% on average over the next years. This is a very strong growth
EPS Next Y9%
EPS Next 2Y6.77%
EPS Next 3Y6.56%
EPS Next 5Y7.89%
Revenue Next Year14.13%
Revenue Next 2Y31.06%
Revenue Next 3Y38.3%
Revenue Next 5Y61.2%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SEER. In the last year negative earnings were reported.
Also next year SEER is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.77%
EPS Next 3Y6.56%
5. Dividend
5.1 Amount
SEER does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SEER INC
NASDAQ:SEER (4/26/2024, 7:15:35 PM)
After market: 1.91 0 (0%)1.91
+0.16 (+9.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap123.71M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.78% | ||
| ROE | -21.74% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 51.09% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 25 | ||
| Quick Ratio | 24.66 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)8.72%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.47%
Revenue growth 3Y193.35%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y